Latest News for: topoisomerase

Edit

DNA Topoisomerase insights hold potential for drug discovery and plant protection

Phys Dot Org 08 Aug 2024
Insights into the function of DNA Topoisomerase VI (Topo VI) may provide a springboard for drug discovery and crop protection ... This analysis delivered a series of findings which improves our knowledge of topoisomerases.
Edit

Global Chemotherapy Research Report 2023: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors Markets, 2017-2022, 2022-2027F, 2032F

PR Newswire 28 Sep 2023
These treatments involve the use of alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and other drugs administered via oral and intravenous routes.
Edit

ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC

PR Newswire 03 Jan 2023
PRO1184 first-in human study initiated and first patients dosed PRO1160 first-in-human study cleared for initiation in the US Both PRO1184 and PRO1160 are based on a novel, proprietary, and internally developed linker-drug technology platform ... .
Edit

ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer

PR Newswire 03 Aug 2022
SUZHOU, China and WOODINVILLE, Wash., Aug. 3, 2022 /PRNewswire/ -- ProfoundBio, an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics, announced that it has received clearance from the U.S ... Dr ... Hunder. Dr ... Dr.
  • 1

Most Viewed

×